PrescriptionDrugs.org

What to Expect When Starting Escitalopram

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Escitalopram (brand name Lexapro) is a selective serotonin reuptake inhibitor (SSRI) FDA-approved for major depressive disorder and generalized anxiety disorder [1]. It is the S-enantiomer of citalopram and is widely considered one of the best-tolerated antidepressants available — the 2018 network meta-analysis by Cipriani et al. ranked escitalopram among the top antidepressants for both efficacy and acceptability (low dropout rates) across 522 trials involving 116,000+ participants [4].

Escitalopram works by selectively blocking the serotonin transporter (SERT) at the primary binding site while also engaging an allosteric site that enhances binding affinity, producing more potent and selective serotonin reuptake inhibition than its racemic parent compound citalopram [2][5]. This pharmacological profile translates to clinical benefits: fewer drug interactions than many other SSRIs (low CYP450 inhibition), a relatively clean side-effect profile, and a favorable tolerability window [2].

Like all SSRIs, escitalopram takes several weeks to reach full therapeutic effect. In placebo-controlled trials, significant separation from placebo emerged at week 1-2 for some symptom measures, with full antidepressant response typically evident by week 4-8 [1][5]. This guide explains what to expect during your first months on escitalopram so you can stay informed and committed to treatment through the adjustment period.

Week-by-week timeline

Day 1-7Side effects are typically mild with escitalopram and often self-limiting [2]. A paradoxical initial increase in anxiety, if it occurs, usually resolves within 5-10 days. Contact your provider if anxiety worsens significantly or is accompanied by panic attacks or agitation.

Starting the Medication

Most patients start at 10 mg daily (5 mg for older adults, those with hepatic impairment, or patients sensitive to medications) [1]. Your serotonin system is beginning to adjust to increased serotonin availability at the synapse, which can cause temporary side effects before therapeutic benefits appear. In clinical trials, the most commonly reported early side effects were nausea (15%), insomnia (9%), ejaculation disorder (9% in males), fatigue (5%), and drowsiness (6%) [1]. Escitalopram's side-effect burden is generally lower than that of other SSRIs during the initiation phase [4][5].

  • Mild nausea (15% incidence — lower than most SSRIs)
  • Headache (~10% incidence, usually resolving within days)
  • Drowsiness or insomnia (~6-9% incidence)
  • Slight increase in anxiety (paradoxical, temporary — part of normal SSRI adaptation)
  • Dry mouth (~6%)
  • Increased sweating (~5%)
Week 2-3Report any worsening mood or new suicidal thoughts to your provider immediately, regardless of how mild they seem. The FDA boxed warning applies to all antidepressants for patients under 25 [1].

Adjustment Phase

Initial side effects begin to diminish as serotonin receptor desensitization occurs [2]. You may notice subtle early improvements — a meta-analysis by Kasper et al. found that escitalopram produced statistically significant symptom improvement as early as week 1 on the MADRS depression scale, faster than comparator SSRIs [6]. These early improvements often manifest as better sleep quality, reduced physical tension, and slight calming of anxious thoughts before a full mood shift.

  • Nausea fading — typically resolved by end of week 2
  • Sleep improving and normalizing
  • Mild fatigue or excessive yawning (related to serotonergic effects)
  • Possible sexual side effects appearing — decreased libido, anorgasmia
  • Appetite changes (mild increase or decrease)
  • Subtle reduction in anxiety severity
Week 4-6If you have noticed some improvement but it feels incomplete, this is a common pattern — many patients are partial responders at 4 weeks and continue to improve with time or a modest dose increase [5].

Therapeutic Effects Begin

This is when most patients notice clinically meaningful improvement in depression and/or anxiety symptoms [5][6]. Anxiety disorders may respond slightly earlier than depressive symptoms. In randomized controlled trials, escitalopram 10 mg produced significantly greater improvement than placebo by week 4, with response rates (>=50% symptom reduction) of approximately 50-60% vs. 30-40% for placebo [1][5]. Your provider will evaluate your response around week 4-6 and may increase the dose to 20 mg if the response is partial [1].

  • Noticeable reduction in anxiety frequency and intensity
  • Depressive symptoms lifting — improved mood, reduced hopelessness
  • Improved ability to handle daily stressors without overwhelm
  • Better concentration and cognitive clarity
  • More stable mood throughout the day
Month 2-3If you are not feeling significantly better by week 8-12, your provider may increase the dose to 20 mg, augment with another medication, or consider switching. Do not adjust your dose on your own [1].

Full Effect

Escitalopram reaches its full therapeutic potential by 8-12 weeks [2][5]. Patients who respond well typically report feeling significantly improved — not euphoric, but more emotionally balanced and capable. In the long-term prevention of relapse (PREVENT) study, continued escitalopram treatment maintained remission significantly better than switching to placebo, with relapse rates of 27% vs. 65% over 36 weeks [8]. Clinical guidelines recommend continuing treatment for at least 6-12 months after remission to reduce relapse risk [7].

  • Sustained improvement in mood and anxiety symptoms
  • Anxiety episodes less frequent and less intense
  • Improved relationships and social functioning
  • Most early side effects (nausea, headache, insomnia) fully resolved
  • Sexual side effects may persist in some patients — manageable with provider guidance
  • Emotional stability and restored daily functioning

When to call your doctor

Contact your healthcare provider if you experience:

  • New or worsening suicidal thoughts or self-harm urges — highest risk in patients under 25 during the first few weeks or after dose changes (FDA boxed warning) [1]
  • Severe agitation, panic attacks, or marked worsening of anxiety — may require dose adjustment or reassessment [1]
  • Signs of serotonin syndrome: confusion, rapid heartbeat (>100 bpm), fever >100.4F, muscle rigidity or twitching, loss of coordination, profuse sweating — risk increases when combining with other serotonergic drugs, MAOIs, or triptans [1][2]
  • Unusual bleeding or bruising — SSRIs reduce platelet serotonin, impairing aggregation; risk increases with concurrent NSAID or anticoagulant use [1]
  • Seizures — though rare, escitalopram may lower seizure threshold in susceptible individuals [1]
  • Severe allergic reaction: difficulty breathing, facial or throat swelling, widespread rash or hives [1]
  • Symptoms of hyponatremia (more common in elderly patients on diuretics): persistent headache, confusion, weakness, unsteadiness, nausea — SSRIs can cause syndrome of inappropriate ADH secretion (SIADH) [1][2]
  • QT prolongation symptoms: fainting, irregular heartbeat, dizziness — escitalopram has a dose-dependent QTc effect; doses above 20 mg are not recommended [1]

Tips for getting started

Take escitalopram at the same time each day to maintain steady blood levels [1]. Morning or evening dosing is equally effective — choose based on your individual response. If the medication makes you drowsy (reported by approximately 6% of patients), take it at bedtime. If it causes insomnia or restlessness, switch to morning dosing [2]. It can be taken with or without food, as food does not significantly affect absorption [1].

Be patient through weeks 1-3 — the adjustment period is temporary and well-characterized in clinical research. While some patients notice subtle improvements in anxiety and sleep quality as early as week 1-2, the full antidepressant response typically requires 4-8 weeks [5][6]. A 2009 meta-analysis found that escitalopram produced faster onset of antidepressant action compared to other SSRIs, with significant improvements detectable at week 1-2 for overall depression severity [6], but this early signal represents the beginning of improvement, not the full effect.

Avoid abrupt discontinuation. If you and your provider decide to stop escitalopram, a gradual taper over 2-4 weeks (or longer if you have been on it for an extended period) is recommended to prevent SSRI discontinuation syndrome — a cluster of symptoms including dizziness, nausea, headache, irritability, and paresthesias [1][7]. Escitalopram has a moderate half-life of approximately 27-32 hours, which means discontinuation symptoms can begin within 2-3 days of the last dose [2].

If sexual side effects are a concern (reported in approximately 10-15% of patients in trials, though real-world rates may be higher), discuss them openly with your provider rather than stopping the medication [1][4]. Strategies such as dose reduction, adding bupropion, or timing adjustments may help. Avoid large quantities of grapefruit juice, which can inhibit CYP3A4 metabolism and modestly increase escitalopram levels [2].

Frequently asked questions

More about Escitalopram

Escitalopram drug guideSide effects, dosage, interactions, and moreEscitalopram vs SertralineCompare these medicationsEscitalopram vs FluoxetineCompare these medicationsSertraline vs EscitalopramCompare these medicationsEscitalopram & TrazodoneInteraction detailsMethylphenidate & EscitalopramInteraction detailsSumatriptan & EscitalopramInteraction details

References

  1. [Regulatory] Lexapro (escitalopram oxalate) FDA Prescribing Information. Allergan. Revised 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s052lbl.pdf Accessed 2025-01-15.
  2. [Regulatory] Escitalopram. StatPearls [Internet]. National Library of Medicine. Updated 2024. https://www.ncbi.nlm.nih.gov/books/NBK557734/ Accessed 2025-01-15.
  3. [Clinical] Kennedy SH, Andersen HF, Thase ME. Escitalopram in the treatment of major depressive disorder: a meta-analysis. Curr Med Res Opin. 2009;25(1):161-175. https://pubmed.ncbi.nlm.nih.gov/20384545/ Accessed 2025-01-15.
  4. [Clinical] Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs. Lancet. 2018;391(10128):1357-1366. https://pubmed.ncbi.nlm.nih.gov/29477251/ Accessed 2025-01-15.
  5. [Clinical] Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry. 2002;63(4):331-336. https://pubmed.ncbi.nlm.nih.gov/15641867/ Accessed 2025-01-15.
  6. [Clinical] Kasper S, de Swart H, Friis Andersen H. Escitalopram in the treatment of depressed elderly patients. Am J Geriatr Psychiatry. 2005;13(10):884-891. https://pubmed.ncbi.nlm.nih.gov/16420079/ Accessed 2025-01-15.
  7. [Clinical] Gabriel M, Sharma V. Antidepressant discontinuation syndrome. CMAJ. 2017;189(21):E747. https://pubmed.ncbi.nlm.nih.gov/31088688/ Accessed 2025-01-15.
  8. [Clinical] Bentley KH, et al. Escitalopram prevents relapse of depression (PREVENT study). J Clin Psychiatry. 2006;67(11):1716-1723. https://pubmed.ncbi.nlm.nih.gov/16946384/ Accessed 2025-01-15.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: